These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38782223)

  • 21. Predictive analysis of COVID-19 eradication with vaccination in India, Brazil, and U.S.A.
    Chaturvedi D; Chakravarty U
    Infect Genet Evol; 2021 Aug; 92():104834. PubMed ID: 33798755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.
    Mediavilla JR; Lozy T; Lee A; Kim J; Kan VW; Titova E; Amin A; Zody MC; Corvelo A; Oschwald DM; Baldwin A; Fennessey S; Zuckerman JM; Kirn T; Chen L; Zhao Y; Chow KF; Maniatis T; Perlin DS; Kreiswirth BN
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
    Hupert N; Marín-Hernández D; Gao B; Águas R; Nixon DF
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.
    Merid Y; Tekleselasie W; Tesfaye E; Gadisa A; Fentahun D; Abate A; Alemu A; Mihret A; Mulu A; Gelanew T
    Front Immunol; 2023; 14():1163688. PubMed ID: 37398668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.
    Ai J; Zhang H; Zhang Y; Lin K; Zhang Y; Wu J; Wan Y; Huang Y; Song J; Fu Z; Wang H; Guo J; Jiang N; Fan M; Zhou Y; Zhao Y; Zhang Q; Liu Q; Lv J; Li P; Qiu C; Zhang W
    Emerg Microbes Infect; 2022 Dec; 11(1):337-343. PubMed ID: 34935594
    [No Abstract]   [Full Text] [Related]  

  • 30. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Will vaccine-derived protective immunity curtail COVID-19 variants in the US?
    Mancuso M; Eikenberry SE; Gumel AB
    Infect Dis Model; 2021; 6():1110-1134. PubMed ID: 34518808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
    van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP
    Front Immunol; 2021; 12():781280. PubMed ID: 34987509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis.
    Lu W; Zeng S; Yao Y; Luo Y; Ruan T
    Front Public Health; 2024; 12():1338208. PubMed ID: 38660347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of nutraceuticals on immunomodulation against viral infections-A review during COVID-19 pandemic in Indian scenario.
    Nathan J; Shameera R; Ramachandran A
    J Biochem Mol Toxicol; 2023 May; 37(5):e23320. PubMed ID: 36799127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2.
    Stoddard M; Sarkar S; Yuan L; Nolan RP; White DE; White LF; Hochberg NS; Chakravarty A
    PLoS One; 2021; 16(7):e0254734. PubMed ID: 34270597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity.
    Mwendwa F; Kanji A; Bukhari AR; Khan U; Sadiqa A; Mushtaq Z; Nasir N; Mahmood SF; Aamir UB; Hasan Z
    J Infect Public Health; 2024 Jun; 17(6):1100-1107. PubMed ID: 38714122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Variants, Vaccines, and Host Immunity.
    Mistry P; Barmania F; Mellet J; Peta K; Strydom A; Viljoen IM; James W; Gordon S; Pepper MS
    Front Immunol; 2021; 12():809244. PubMed ID: 35046961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multi-strain model with asymptomatic transmission: Application to COVID-19 in the US.
    Gao S; Shen M; Wang X; Wang J; Martcheva M; Rong L
    J Theor Biol; 2023 May; 565():111468. PubMed ID: 36940811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How bad is Omicron? What scientists know so far.
    Callaway E; Ledford H
    Nature; 2021 Dec; 600(7888):197-199. PubMed ID: 34857948
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccination compartmental epidemiological models for the delta and omicron SARS-CoV-2 variants.
    Cuevas-Maraver J; Kevrekidis PG; Chen QY; Kevrekidis GA; Drossinos Y
    Math Biosci; 2024 Jan; 367():109109. PubMed ID: 37981262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.